Shnayder, N.A.,
Grechkina, V.V.,
Khasanova, A.K.,
Bochanova, E.N.,
Dontceva, E.A.,
Petrova, M.M.,
Asadullin, A.R.,
Shipulin, G.A.,
Altynbekov, K.S.,
Al-Zamil, M.,
Nasyrova, R.F. (2023) of
therapeutic and toxic metabolites of VPA in the human body. Thus, VPA is considered a component of disease
and significant long-term disabilities among survivors, underscoring the urgent need for innovative
therapeuticYANG, G.,
LIU, Z.,
CHEN, X.,
WANG, X.,
ZHANG, D.,
YANG, Z.,
SUN, J.,
XUE, L.,
GAO, M.,
LI, L.,
GAREEV, I.,
ZHAO, S.,
WANG, L.,
DONG, Q.,
ZHOU, Q.,
YI, R.,
AI, J. (2019) -linked immunosorbent assay, and apoptotic proteins were examined by Western blotting. Direct
targeting of CX3CL1/CX3CR1